🔴 Senti Biosciences is trading 5.5% down in after-hours trading with no identified company-specific explanation

Senti Biosciences is trading $0.22, down 5.45% in after-hours trading, with no identified company-specific announcement explaining the decline.

• The latest confirmed development was the October 15 shareholder approval of the merger and authorization of a possible 1-for-20 to 1-for-50 reverse split; that vote does not establish the cause of this move.
• Major U.S. indexes finished higher on October 20, so broad-market weakness does not clearly explain the drop.
• No volume or unusual-trading data was verified.